Gujarat Venture Finance Ltd. (GVFL) has acquired 26.8% stake in Pegasus Semiconductors Pvt. Ltd. for Rs 3.5 crore.

Ahmedabad-based Pegasus offers energy efficient and low cost lighting solutions using LEDs and solar technologies. Among various products of the company, the majority of business comes from 220V LED Street Light System, LED based Solar Home Lighting System and Street Lighting System.

Mumbai-headquartered Dolphin Offshore Enterprises India Ltd has received two orders worth $ 16 million for charter hire of DP / DSV Vessels.

The company has secured first contract worth US$ 10 million from Leighton India Pvt. Ltd, which is expected to be completed in 3 months.

While, the second contract, valued at US$ 6 million has been picked from Punj Lloyd Ltd, schedule to be completed in 2 months.

Soft-drinks giant Pepsi would invest $500-million (Rs 2,200 crore) in coming three years. It is disclosed by the CEO and global chairman of PepsiCo. Ms. Indra Nooyi. She was here in Gurgaon (Haryana) to attend the first ever executive committee meeting of company in India. The company has already invested over $1 billion in India.

Though Tata Motors authorities are eagerly awaiting to resume work on the project Nano, they still feel that the situation in Singur has not completely calmed down and it may be risky for them to return.. The information was disclosed by the Chief Minister of West Bengal, Mr Buddhadeb Bhattacharjee.

On Wednesday during a press conference, he announced, “They are closely observing the situation and when they feel the situation is normal they will come back.”

On Tuesday, the CM, talks with its chairman Ratan Tata regarding the issue.

The US Food and Drug Administration have put its report on its website. Some of the products of Indian medicine major, Ranbaxy do not conform to the safety standards set by the inspection agency of US. It has banned 31 drugs produced by Ranbaxy. The agency had not mentioned the name of Daiichi Sankyo, the Japanese firm which is in the process to buy the Indian medicine company in its report